PlainRecalls
FDA Devices Critical Class I Ongoing

RELIANCE 4-FRONT, endocardial cardioversion/defibrillation and pace/sense lead, Permanent Defibrillator Electrodes; Model Nos. 0654, 0655, 0657, 0658, 0682, 0683, 0685, 0686, 0692, 0693, 0695, 0696

Reported: August 27, 2025 Initiated: July 24, 2025 #Z-2327-2025

Product Description

RELIANCE 4-FRONT, endocardial cardioversion/defibrillation and pace/sense lead, Permanent Defibrillator Electrodes; Model Nos. 0654, 0655, 0657, 0658, 0682, 0683, 0685, 0686, 0692, 0693, 0695, 0696

Reason for Recall

Affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. Most serious harm is death or need for cardiac resuscitation.

Details

Units Affected
247,702 US; 344,670 OUS
Distribution
Worldwide Distribution. US nationwide. International distribution worldwide.
Location
Saint Paul, MN

Frequently Asked Questions

What product was recalled?
RELIANCE 4-FRONT, endocardial cardioversion/defibrillation and pace/sense lead, Permanent Defibrillator Electrodes; Model Nos. 0654, 0655, 0657, 0658, 0682, 0683, 0685, 0686, 0692, 0693, 0695, 0696. Recalled by Boston Scientific Corporation. Units affected: 247,702 US; 344,670 OUS.
Why was this product recalled?
Affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. Most serious harm is death or need for cardiac resuscitation.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 27, 2025. Severity: Critical. Recall number: Z-2327-2025.